Bill C-9 is Canada’s legislation to implement the WTO General Council Decision of 30 August 2003. The bill, therefore, should fully reflect the flexibility that the WTO Decision creates for countries to use compulsory licensing to import cheaper, generic phramaceutical products.
Global Access to Medicines: Will Canada Meet the Challenge? – A Submission to the Standing Committee on Industry, Science and Technology regarding Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
This entry was posted in Advocacy, English, French, Publications. Publication Topics: Access to Medicines. Bookmark the permalink. Both comments and trackbacks are currently closed.
Author
Canadian HIV/AIDS Legal Network
Topics
Access to Medicines
Doc Type
Advocacy
Language
English, French